1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020.Available from: www.ginasthma.org
2. Chuchalin A.G., Khaltaev N., Antonov N. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation// International Journal of COPD 2014:9 963-974
3. Национальная программа «Бронхиальная астма у детей. Стратегия лечения и профилактика», IV издание. - M., 2012. - 182 с.
4. Centers for Disease Control and Prevention, Asthma Data http://www.cdc.gov/asthma/most_recent_data.htm
5. Krahn MD Berka C., Langlois P. et al direct and indirect costs of asthma in Canada, 1990. Can Med Assoc J 1996; 154:821-831.
6. Weber E.J., Silverman R.A., Callaham M.L. et al A prospective multicenter study factors associated with hospital admission among adults with acute asthma. Am J Med 2002; 113 :371-378
7. Braman S.S., Kaermmerhen J.T. Intensive care of status asthmaticus: a 10-year experience. JAMA 1990; 264: 366-368.
8. Salmeron S., Liard R., Elkharrat D. et al. Asthma severity adequacy of management in accident and emergency departments in France: a prospective study. Lancet 2001; 358:629-635.
9. Krishnan V., Diette G.B., Rand C.S. et al Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006 15;174(6):633-8.
10. Ненашева H.M. Клинические фенотипы aтoпичecкoй бронхиальной астмы: диагностика и лечение. Palmarium Academic Publishing, 2012, 319 р.
11. Moore W., Meyers D., Wenzel S., Teague G., Li H., et al. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010 Feb 15; 181(4): 315-323
12. Pearce N., Pekkanen J., Beasley R. How much asthma is really attributable to atopy? Thorax 1999; 54: 268-272
13. Mellis C. Respiratory noises: how useful are they clinically? Pediatr Clin North Am 2009; 56: l-17,ix.
14. Cano Garcinuno A., Mora Gandarillas I., Group SS. Early patterns of wheezing in asthmatic and nonasthmatic children. Eur Respir J 2013; 42:1020-8.404.
15. Just J., Saint-Pierre P., Gouvis-Echraghi R., et al. Wheeze phenotypes in young children have different courses during the preschool period. Ann Allergy Asthma Immunol 2013; 111: 256-61.el.
16. O'Byrne P.M., Reddel H.K., Eriksson G., et al. Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010; 36: 269-76.
17. Thomas M., Kay S., Pike J., et al. The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey. Prim Care Respir J 2009; 18:41-9.
18. Juniper E.F., Svensson K., Mork A.C., Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005; 99: 553-8.
19. Kerkhof Μ, Tran TN, van den Berge Μ, Brusselle GG, Gopalan G, Jones RCM, Kocks JWH, Menzies-Gow А, Nuevo J, Pavord ID, Rastogi S, Price DB. Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study. PLoS One. 2018 Jul 25;13(7):e0201143,
20. Price DB, Rigazio A, Campbell JD, Bleecker ER, Corrigan CJ, Thomas M, Wenzel SE, Wilson AM, Small MB, Gopalan G, Ashton VL, Burden A, Hillyer EV, Kerkhof M, Pavord ID. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015 Nov;3(11):849-58,
21. Albers FC, Licskai C, Chanez P, Bratton DJ, Bradford ES, Yancey SW, Kwon N, Ouirce S. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma. Respir Med. 2019 Nov;159:105806,
22. Bush A. Management of asthma in children. Minerva Pediatr. 2018 Oct;70(5):444-457
23. Rath N, Raje N, Rosenwasser L. Immunoglobulin Ε as a Biomarker in Asthma. Immunol Allergy Clin North Am. 2018 Nov;38(4):587-597
24. Ahlstedt S., Murray C.S. In vitro diagnosis of allergy: how to interpret IgE antibody results in clinical practice. Prim Care Respir J 2006; 15: 228-36.
25. Miller M.R., Hankinson J., Brusasco V., et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38
26. Levy M.L., Ouanjer P.H., Booker R., et al. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG) document, in association with the Association for Respiratory Technology & Physiology (ARTP) and Education for Health. Prim Care Respir J 2009; 18:130-47.
27. Методические рекомендации по использованию метода спирометрии. Российское респираторное общество. Утверждены Минздравом России в 2016 г.- M., - 2016 - 36 с: 6-7.
28. Pellegrino R., Viegi G., Brusasco V., et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-68.
29. Tan W.C., Vollmer W.M., Lamprecht B., et al. Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study. Thorax 2012; 67: 718-26.
30. Crapo R.O., Casaburi R., Coates A.L., et al. Guidelines for methacholine and exercise challenge testing-1999.Am J Respir Crit Care Med 2000; 161: 309-29.
31. Swartz E, Lang D. When should a methacholine challenge be ordered for a patient with suspected asthma? Cleve Clin J Med. 2008 Jan;75(l):37-40. doi: 10.3949/ccjm.75.1.37. PMID: 18236728.
32. Parsons J.P., Hallstrand T.S., Mastronarde J.G., et al. An official American Thoracic Society clinical practice guideline: exerciseinduced bronchoconstriction. Am J Respir Crit Care Med 2013; 187: 1016-27
33. Reddel H.K., Taylor D.R., Bateman E.D., et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations:
standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.